Quantcast
Last updated on April 19, 2014 at 21:20 EDT

Generics and Biosimilars in Central and Eastern Europe 25-26 June – Warsaw, Poland

April 4, 2013

LONDON, April 4, 2013 /PRNewswire/ –

Having shown steady recovery from the global economic crisis, the CEE region continues
to gain investment from foreign market players, quite a few of which have already
successfully established their business in the region. Local market players like
Polpharma, Gedeon Richter, Krka, Zentiva and Lek (recently acquired by the Novartis
Group), have an impressively strong position within the entire CEE region, becoming a
growing subject of interest for the Multinationals and their portfolio ambitions.

With this in mind, CPhI Conferences, in partnership with Polpharma, is proud to
present its inaugural conference on Generics and Biosimilars in Central and Eastern Europe
which has been designed to assess regulatory hurdles, share best practice and highlight
ample market opportunities.

We are delighted to be joined by high-quality industry professionals including IMS
Health, MHRA, Janssen Pharmaceuticals, Egis, Polpharma, Selvita and many more. With expert
speakers in generic and biosimilar development across the merging markets of CEE, this
conference offers the opportunity to network and debate with leaders in this field.

Over the course of two intensive days there will be practical and informative sessions
on the current and future market trends, innovation strategies in generic and biosimilar
development, identifying the crucial factors in successful partnerships, commercialisation
and market access. This is an essential opportunity to gather the information you need to
advance your business strategy and establish yourself in this lucrative market.

For the full programme including a list of the expert speakers and to register please
visit http://www.cphi-cee.com

About CPhI Conferences:

CPhI Conferences deliver the latest pharma market insight, in-depth case studies and
exceptional networking opportunities through a programme of high-level conferences. The
worldwide series of events, spanning four continents, provides the optimum forum for you
to learn, make new business connections and identify the latest growth opportunities.
Delivered by expert teams in each region, every conference is extensively researched with
leading professionals, ensuring that CPhI Conferences tackle the most business critical
issues facing the pharma industry today.

http://www.cphiconferences.com

        For further information, please contact:

        Svetlana Fathers
        Senior Conference Producer
        CPhI Conferences
        Tel: +44(0)20-7955-3973
        E-mail: svetlana.fathers@ubm.com

SOURCE CPhI Conferences


Source: PR Newswire